Dr Reddy's Laboratories
RDY · NATIONAL
$13.21−$0.02 (−0.15%)TodayMarket closed ·
Prev close $13.23
About RDY
- Employees
- 27,527
- Headquarters
- Hyderabad, Telangana
- Listed
- Jan 1, 1986
- Sector
- Health Care
- Industry
- Pharmaceuticals
- Website
- drreddys.com
Leadership
| Name | Title | Since |
|---|---|---|
| Kallam Reddy | — | 2022 |
| Gunupati Prasad | — | 2001 |
| Erez Israeli | — | — |
| Mannam Narasimham | — | 2024 |
| Patrick Aghanian | — | — |
| M. Ramana | — | — |
| Deepak Sapra | — | — |
| Phanimitra B | — | — |
| K. Singh | — | — |
| Sushrut Kulkarni | — | — |
| Sanjay Sharma | — | — |
| Leo Puri | — | — |
| Claudio Albrecht | — | — |
| Kodumudi Krishnan | — | — |
| Arun Kumar | — | — |
| Sanjiv Mehta | — | — |
| Alpna Seth | — | — |
| Shikha Sharma | — | — |
| Chan Wan | — | — |
| Richa Periwal | — | 2025 |
Revenue by product and region
Fiscal year ended Mar 31, 2026: $3.58B total revenue
By product
- Global Generics [Member]$299.03B8352.9%
- Pharmaceutical Services and Active Ingredients [Member]$34.77B971.3%
- Other segment [Member]$2.13B59.4%
By region
- Others Countries Country [Member]$118.72B3316.1%
- UNITED STATES$117.89B3293.1%
- India Country [Member]$64.54B1802.7%
- Russia Country [Member]$34.79B971.7%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.